Abstract:Uneven oxygen supply in solid tumors leads to hypoxic and normoxic regions. Hypoxic cells exhibit increased secretion of lactate, which creates an acidic tumor microenvironment (TME). This acidic TME is positively associated with tumor metastasis. Despite the increased metastatic capacity of hypoxic cells, they are located relatively further away from the blood vessels and have limited access to the circulatory system. Studies have shown that cancer stem cells (CSCs) are enriched for tumor metastasis-initiating cells and generally undergo aerobic respiration, which could be enhanced by lactate. We therefore hypothesized that TME-derived lactate may promote the metastasis of normoxic CSCs. In the present study, the abundance of hypoxic and normoxic CSCs was analyzed in primary CRC tumors. It was found that the proportion of normoxic CSCs was positively associated with tumor stage. Using two human CRC cell lines, LoVo and SW480, and a patient-derived xenograft (XhCRC), it was found that treatment with lactate promoted normoxic CSC metastasis. Metabolism analysis indicated that, upon treatment with lactate, oxidative phosphorylation (OXPHOS) activity in normoxic CSCs was enhanced, whereas hypoxic CSCs were rarely altered. At the molecular level, the expression of peroxisome proliferator-activated receptor-γ coactivator-1α (PGC-1α), a master regulator of lactate oxidation, was found to be elevated in normoxic CSCs. Furthermore, PGC-1α knockdown markedly reduced the metastatic potential of normoxic CSCs. Notably, both the PGC-1α-mediated OXPHOS activity and metastatic potential were impaired when hypoxia-inducible factor-1α (HIF-1α) was activated in normoxic CSCs. Together, these findings provide a therapeutic strategy against tumor metastasis through the targeting of PGC-1α and, thus, the suppression of lactate-feeding OXPHOS in normoxic CSCs may improve the therapeutic benefit of patients with cancer, particularly CRC.

Lactate in the Regulation of Tumor Microenvironment and Therapeutic Approaches

Lactate Contribution to the Tumor Microenvironment: Mechanisms, Effects on Immune Cells and Therapeutic Relevance

Lactate Promotes Metastasis of Normoxic Colorectal Cancer Stem Cells Through PGC-1α-mediated Oxidative Phosphorylation

Lactate in the tumor microenvironment: A rising star for targeted tumor therapy

Recent Progress in the Therapeutic Modulation of Lactate for Cancer Treatment

Tumor Microenvironment: Lactic Acid Promotes Tumor Development

Lactate: the Mediator of Metabolism and Immunosuppression

The Tumor Metabolic Microenvironment: Lessons from Lactate.

Tumor-Derived Lactate Creates a Favorable Niche for Tumor via Supplying Energy Source for Tumor and Modulating the Tumor Microenvironment

The Tumor Metabolic Microenvironment: Lessons from Lactate

Lactate in the tumour microenvironment: From immune modulation to therapy

Lactate and Lactylation: Behind the Development of Tumors

The emerging role of lactate in tumor microenvironment and its clinical relevance

Intervention on lactate in cancer: A promising approach for the development of cancer therapeutics

Lactate metabolic pathway regulates tumor cell metastasis and its use as a new therapeutic target

Tumor lactic acid: a potential target for cancer therapy

Unveiling the veil of lactate in tumor-associated macrophages: a successful strategy for immunometabolic therapy

Crosstalk between lactate and tumor-associated immune cells: clinical relevance and insight

From metabolic byproduct to immune modulator: the role of lactate in tumor immune escape

Lactate from the tumor microenvironment - A key obstacle in NK cell-based immunotherapies

Targeting L-Lactate Metabolism to Overcome Resistance to Immune Therapy of Melanoma and Other Tumor Entities